Document Detail


Failure of calcium antagonistic agents to prevent hepatotoxicity induced by diclofenac.
MedLine Citation:
PMID:  8532609     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Diclofenac (0.5-2 mM) dose- and time-dependently reduces the viability of isolated hepatocytes. This effect cannot be counteracted by the calcium channel blockers diltiazem (0.05-0.1 mM) and verapamil (0.05-0.5 mM), the calmodulin antagonist calmidazolium (0.01 mM) or Quin 2-AM (0.1 mM), an intracellular calcium chelating agent. On the contrary, verapamil even accentuates the toxic effects of diclofenac. It is concluded from these results, that diclofenac causes cell damage by other mechanisms than calcium overload.
Authors:
G Schmitz; H Lepper; C J Estler
Related Documents :
6487889 - Changing surface charge with salicylate differentiates between subgroups of calcium-ant...
6147759 - Differential effects of nifedipine, verapamil, and diltiazem on noradrenaline-induced c...
7602609 - The effects of modulation of calcium influx through the voltage-sensitive calcium chann...
2410679 - Modulation of calcium ion influx by the 1,4-dihydropyridines nifedipine and bay k 8644.
712619 - The effects of verapamil and lidocaine on the automatic depolarizations in guinea-pig v...
3567229 - Effects of ca2+-channel antagonists on nucleoside and nucleobase transport in human ery...
3023549 - Forskolin enhancement of acetylcholine-evoked cyclic amp formation and catecholamine re...
10359679 - Na+/ca2+ exchange current in ventricular myocytes of fish heart: contribution to sarcol...
22622459 - Tissue kallikrein activation of the epithelial na channel.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Pharmacology & toxicology     Volume:  77     ISSN:  0901-9928     ISO Abbreviation:  Pharmacol. Toxicol.     Publication Date:  1995 Jul 
Date Detail:
Created Date:  1996-01-29     Completed Date:  1996-01-29     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8702180     Medline TA:  Pharmacol Toxicol     Country:  DENMARK    
Other Details:
Languages:  eng     Pagination:  32-5     Citation Subset:  IM    
Affiliation:
Institute for Experimental and Clinical Pharmacology and Toxicology, University of Erlangen-Nürnberg, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Analysis of Variance
Animals
Anti-Inflammatory Agents, Non-Steroidal / antagonists & inhibitors,  toxicity*
Calcium Channel Blockers / pharmacology*
Cell Survival / drug effects
Cells, Cultured
Chelating Agents / pharmacology
Diclofenac / antagonists & inhibitors,  toxicity*
Diltiazem / pharmacology
Dose-Response Relationship, Drug
Drug Interactions
Liver / cytology,  drug effects*
Male
Rats
Rats, Wistar
Verapamil / pharmacology
Chemical
Reg. No./Substance:
0/Anti-Inflammatory Agents, Non-Steroidal; 0/Calcium Channel Blockers; 0/Chelating Agents; 15307-86-5/Diclofenac; 42399-41-7/Diltiazem; 52-53-9/Verapamil

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Uptake and transport of manganese in primary and secondary olfactory neurones in pike.
Next Document:  Xanthine oxidase mediates paraquat-induced toxicity on cultured endothelial cell.